Karen Lingnau

2.3k citations

34 papers · 1.9k indexed · h-index 24

Co-authors: Alexander von Gabain Edgar Schmitt Peter Andersen Michael Buschle Eszter Nagy Ida Rosenkrands Jaap T. van Dissel Ingrid Kromann
Topics: Immune Cell Function and Interaction (14 papers)Immunotherapy and Immune Responses (14 papers)Immune Response and Inflammation (13 papers)
Cited by: Immunology Infectious Diseases Microbiology
Journals: Immunity The Journal of Immunology PLoS ONE
Partner nations: Austria Germany Denmark

In The Last Decade

Karen Lingnau

34 papers receiving 1.9k citations

Peers

Countries citing papers authored by Karen Lingnau

Since Specialization

Citations

This map shows the geographic impact of Karen Lingnau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Lingnau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Lingnau more than expected).

Fields of papers citing papers by Karen Lingnau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Lingnau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Lingnau. The network helps show where Karen Lingnau may publish in the future.

Co-authorship network of co-authors of Karen Lingnau

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Lingnau. A scholar is included among the top collaborators of Karen Lingnau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Lingnau. Karen Lingnau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Two-Component Adjuvant IC31® Boosts Type I Interferon Production of Human Monocyte-Derived Dendritic Cells via Ligation of Endosomal TLRs 2013 ·PLoS ONE ·Attila Szabó,Péter Gogolák,Kitti Pázmándi,Katalin Kis‐Tóth,(unknown),Benjamin Wizel,Karen Lingnau,Attila Bácsi,Bence Réthi,Éva Rajnavölgyi	22
2	A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity 2012 ·PLoS ONE ·Laura Pattacini,Gregory J. Mize,Jessica B. Graham,(unknown),(unknown),Karen Lingnau,Benjamin Wizel,Beatriz Perdiguero,Mariano Estéban,Giuseppe Pantaleo,(unknown),(unknown),M. Juliana McElrath,Jennifer M. Lund	10
3	Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells 2010 ·Immunity ·Valérie Staudt,(unknown),Matthias Klein,Karen Lingnau,Sebastian Reuter,(unknown),Bastian Gerlitzki,Markus Hoffmann,Alexander Ulges,Christian Taube,Nina Dehzad,Marc A. Becker,Michael Stassen,Andrea Steinborn,Michael Lohoff,Hansjörg Schild,Edgar Schmitt,Tobias Bopp	429
4	Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers 2010 ·Vaccine ·Jaap T. van Dissel,Sandra M. Arend,Corine Prins,Peter Fibiger Bang,Pernille N. Tingskov,Karen Lingnau,Jan Nouta,Michèl R. Klein,Ida Rosenkrands,Tom H. M. Ottenhoff,Ingrid Kromann,T. Mark Doherty,Peter Andersen	166
5	First in humans: A new molecularly defined vaccine shows excellent safety and strong induction of long-livedMycobacterium tuberculosis-specific Th1-cell like responses 2010 ·Human Vaccines ·Tom H. M. Ottenhoff,T. Mark Doherty,Jaap T. van Dissel,Peter Fibiger Bang,Karen Lingnau,Ingrid Kromann,Peter Andersen	52
6	IC31^®, a Two‐Component Novel Adjuvant Mixed with a Conjugate Vaccine Enhances Protective Immunity against Pneumococcal Disease in Neonatal Mice 2009 ·Scandinavian Journal of Immunology ·Thorunn A. Olafsdottir,Karen Lingnau,Eszter Nagy,Ingileif Jónsdóttir	43
7	Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity 2009 ·Vaccine ·(unknown),Andreas Pilz,Olivia Simma,Karen Lingnau,Alexander von Gabain,Birgit Strobl,Mathias Müller,Thomas Decker	35
8	Dendritic Cells Require STAT-1 Phosphorylated at Its Transactivating Domain for the Induction of Peptide-Specific CTL 2009 ·The Journal of Immunology ·Andreas Pilz,(unknown),Silvia Stockinger,Olivia Simma,Ulrich Kalinke,Karen Lingnau,Alexander von Gabain,Dagmar Stoiber,Veronika Sexl,Thomas Kolbe,Thomas Rülicke,Mathias Müller,Thomas Decker	30
9	Protective anti‐mycobacterial T cell responses through exquisite in vivo activation of vaccine‐targeted dendritic cells 2008 ·European Journal of Immunology ·Arun T. Kamath,(unknown),Anne-Françoise Rochat,Else Marie Agger,Karen Lingnau,Alexander von Gabain,Peter Andersen,Paul‐Henri Lambert,Claire‐Anne Siegrist	44
10	Unique membrane‐interacting properties of the immunostimulatory cationic peptide KLKL₅KLK (KLK) 2008 ·Cell Biology International ·Michael Aichinger,(unknown),Siegfried Reipert,Wolfgang Zauner,Péter Bogner,Elisabeth M. Froschauer,Karin Nowikovsky,Karen Lingnau,Alexander von Gabain,Rudolf J. Schweyen,Tamás Henics	7
11	Adult-Like Anti-Mycobacterial T Cell and In Vivo Dendritic Cell Responses Following Neonatal Immunization with Ag85B-ESAT-6 in the IC31® Adjuvant 2008 ·PLoS ONE ·Arun T. Kamath,Anne-Françoise Rochat,(unknown),Else Marie Agger,Karen Lingnau,Peter Andersen,Paul‐Henri Lambert,Claire‐Anne Siegrist	56
12	Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31 2006 ·Vaccine ·Else Marie Agger,Ida Rosenkrands,Anja Weinreich Olsen,Graham Hatch,Ann Williams,(unknown),Karen Lingnau,Alexander von Gabain,(unknown),Karen Smith Korsholm,Peter Andersen	100
13	IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses 2006 ·Vaccine ·Carola Schellack,(unknown),Alena Egyed,Jörg H. Fritz,(unknown),(unknown),(unknown),Wolfgang Zauner,(unknown),Shizuo Akira,Alexander von Gabain,Michael Buschle,Karen Lingnau	132
14	Poly-l-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines 2002 ·Vaccine ·Karen Lingnau,Alena Egyed,Carola Schellack,Frank Mattner,Michael Buschle,Walter Schmidt	48
15	Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma 2001 ·Journal of Allergy and Clinical Immunology ·Susetta Finotto,Michael Buerke,Karen Lingnau,Edgar Schmitt,Peter R. Galle,(unknown)	50
16	Defined Synthetic Vaccines 2001 ·Biological Chemistry ·Wolfgang Zauner,Karen Lingnau,Frank Mattner,Alexander von Gabain,Michael Buschle	21
17	Fetal Calf Serum-Free Generation of Functionally Active Murine Dendritic Cells Suitable for In Vivo Therapeutic Approaches 2000 ·Journal of Investigative Dermatology ·Gabriele Müller,Anke Müller,Helmut Jonuleit,Kerstin Steinbrink,(unknown),(unknown),Jürgen Knop,Alexander Enk,Karen Lingnau,Edgar Schmidt	25
18	H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines 2000 ·Immunogenetics ·(unknown),Cláudia Scheuer,Karen Lingnau,Torsten E. Reichert,Edgar Schmitt,Michael Loos,Markus Maeurer	16
19	MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance? 2000 ·British Journal of Cancer ·W. Walter,Karen Lingnau,Edgar Schmitt,Michael Loos,Markus Maeurer	19
20	Newly synthesized proteoglycans in pseudoachondroplasia 1988 ·Bone ·Michael Beck,Karen Lingnau,Jürgen W. Spranger	3

About Karen Lingnau

Karen Lingnau is a scholar working on Immunology, Microbiology and Infectious Diseases, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), Immunotherapy and Immune Responses (14 papers) and Immune Response and Inflammation (13 papers). The work is most often cited by research in Immunology (1.3k citations), Infectious Diseases (583 citations) and Microbiology (148 citations). Karen Lingnau has collaborated with scholars based in Austria, Germany and Denmark. Frequent co-authors include Alexander von Gabain, Edgar Schmitt, Peter Andersen, Michael Buschle, Eszter Nagy, Ida Rosenkrands, Jaap T. van Dissel, Ingrid Kromann, Tom H. M. Ottenhoff and Peter Fibiger Bang. Their work appears in journals such as Immunity, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact